IL6 and neoplasm: Interestingly, ASK-1 inhibition reduces TLR-4-mediated inflammatory responses, including IL-6, IL-8, soluble VCAM, and G-CSF secretion from ECs [75], suggesting that EC-produced soluble immune mediators are involved in the regulating accessibility of immune cell types to tumor regions.